Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Primary Purpose
Urinary Tract Infections, Infection, Urologic Diseases
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
cranberry juice
placebo beverage
Sponsored by
About this trial
This is an interventional prevention trial for Urinary Tract Infections focused on measuring Urinary tract infection, Recurrent urinary tract infection, Cranberry, Prevention, E-coli
Eligibility Criteria
Inclusion Criteria:
- Subject has had at least 2 episodes of a UTI treated by a healthcare professional in the last year and at least 1 treated UTI within the last 6 months.
- Subject is willing to avoid listed Vaccinium products (including cranberry juice, cranberries, craisins, blueberries, cranberry/blueberry powders, pills, or supplements, probiotics) for 2 weeks prior to enrollment and throughout intervention.
- Subject agrees to avoid probiotic dietary supplements for 2 weeks prior to enrollment and throughout intervention.
- Subject agrees to limit all probiotic-containing foods/yogurt and yogurt-containing products to no more than an 8 oz serving/d within 2 weeks prior to enrollment and throughout intervention.
- Subject is willing to limit all soda, pop or energy drinks (diet or regular sweetened) to < 20 oz/d within 2 weeks prior to and throughout intervention.
Exclusion Criteria:
- Subject has an in-dwelling catheter, polycystic disease, interstitial cystitis, previous urological surgery, stones, or anatomical abnormalities of the urinary tract, spinal cord injury, immuno-compromised conditions, severe renal impairment, or multiple sclerosis.
- Subject has a history of antibiotic prophylaxis use for UTI. A 2-week washout period prior to enrollment will be allowed.
- Subject has a body mass index (BMI) >40.0 kg/m2.
- Subjects with diabetes mellitus and HbA1C >8.0% prior to enrollment.
- Subject has diabetes mellitus treated with insulin.
- Subject has an active infection or sign/symptoms of an infection (i.e., including a UTI).
- Subject has used oral anti-coagulants within the last 4 weeks.
- Subject has a history or presence of cancer in the prior two years, except for nonmelanoma skin cancer.
- Subject is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period.
Sites / Locations
- Ocean Spray Cranberries Research Sites
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
cranberry juice
Placebo
Arm Description
cranberry juice beverage at a dose of one 8 oz. beverage per day for six months
placebo beverage at a dose of one 8 oz. beverage per day for six months
Outcomes
Primary Outcome Measures
The primary outcome variable will be UTI incidence density, defined as the semi-annualized number of UTIs in each group, adjusted for susceptible time under observation.
Secondary Outcome Measures
Time from randomization to first clinical UTI. Time from randomization to first clinical UTI w/ pyuria. Time from randomization to first clinical UTI w/ microbiological verification. The fraction of subjects w/ one or more episode(s) of clinical UTI.
Full Information
NCT ID
NCT01776021
First Posted
January 23, 2013
Last Updated
April 24, 2015
Sponsor
Ocean Spray Cranberries, Inc.
Collaborators
Biofortis Clinical Research, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT01776021
Brief Title
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Official Title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Study Type
Interventional
2. Study Status
Record Verification Date
November 2013
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
April 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ocean Spray Cranberries, Inc.
Collaborators
Biofortis Clinical Research, Inc.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare the effects of a cranberry juice beverage on rates of Urinary tract infection (UTI) recurrence in women with a history of UTI.
Detailed Description
Urinary tract infections (UTI) are the second most common infection of any organ system and the most common urological disease in the United States, with a total annual cost of more than $3.5 billion. Although UTIs can occur in both men and women, they are about 50 times more common in adult women than adult men. It is estimated that 25% of women diagnosed with a primary UTI will suffer a recurrence within two to three months. While no universal definition has been accepted, recurrent UTI is usually defined as three episodes in the last 12 months or two episodes in the last six months following initial infection. In an estimated 75 to 95% of cases of uncomplicated UTI, Escherichia coli (E. coli) is the underlying cause.
Cranberries have historically been associated with urinary tract health, but only recently has the biologic plausibility of cranberry use in the prevention of UTI been addressed. Current research suggests that A-type proanthocyanidins, a specific class of polyphenolic compounds found uniquely abundant in cranberries, inhibit adhesion of bacteria (including multidrug resistant E.coli) to cultured epithelial cells of the urinary tract.
This study will compare the effects of a cranberry juice beverage vs placebo on rates of UTI recurrence in women with a history of UTI.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Tract Infections, Infection, Urologic Diseases
Keywords
Urinary tract infection, Recurrent urinary tract infection, Cranberry, Prevention, E-coli
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
330 (Actual)
8. Arms, Groups, and Interventions
Arm Title
cranberry juice
Arm Type
Active Comparator
Arm Description
cranberry juice beverage at a dose of one 8 oz. beverage per day for six months
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
placebo beverage at a dose of one 8 oz. beverage per day for six months
Intervention Type
Other
Intervention Name(s)
cranberry juice
Intervention Description
cranberry juice beverage at a dose of one 8 oz. beverage per day for six months
Intervention Type
Other
Intervention Name(s)
placebo beverage
Intervention Description
placebo beverage at a dose of one 8 oz. beverage per day for six months
Primary Outcome Measure Information:
Title
The primary outcome variable will be UTI incidence density, defined as the semi-annualized number of UTIs in each group, adjusted for susceptible time under observation.
Time Frame
six months
Secondary Outcome Measure Information:
Title
Time from randomization to first clinical UTI. Time from randomization to first clinical UTI w/ pyuria. Time from randomization to first clinical UTI w/ microbiological verification. The fraction of subjects w/ one or more episode(s) of clinical UTI.
Time Frame
six months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Subject has had at least 2 episodes of a UTI treated by a healthcare professional in the last year and at least 1 treated UTI within the last 6 months.
Subject is willing to avoid listed Vaccinium products (including cranberry juice, cranberries, craisins, blueberries, cranberry/blueberry powders, pills, or supplements, probiotics) for 2 weeks prior to enrollment and throughout intervention.
Subject agrees to avoid probiotic dietary supplements for 2 weeks prior to enrollment and throughout intervention.
Subject agrees to limit all probiotic-containing foods/yogurt and yogurt-containing products to no more than an 8 oz serving/d within 2 weeks prior to enrollment and throughout intervention.
Subject is willing to limit all soda, pop or energy drinks (diet or regular sweetened) to < 20 oz/d within 2 weeks prior to and throughout intervention.
Exclusion Criteria:
Subject has an in-dwelling catheter, polycystic disease, interstitial cystitis, previous urological surgery, stones, or anatomical abnormalities of the urinary tract, spinal cord injury, immuno-compromised conditions, severe renal impairment, or multiple sclerosis.
Subject has a history of antibiotic prophylaxis use for UTI. A 2-week washout period prior to enrollment will be allowed.
Subject has a body mass index (BMI) >40.0 kg/m2.
Subjects with diabetes mellitus and HbA1C >8.0% prior to enrollment.
Subject has diabetes mellitus treated with insulin.
Subject has an active infection or sign/symptoms of an infection (i.e., including a UTI).
Subject has used oral anti-coagulants within the last 4 weeks.
Subject has a history or presence of cancer in the prior two years, except for nonmelanoma skin cancer.
Subject is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kevin Maki, PhD
Organizational Affiliation
Biofortis Clinical Research, Inc.
Official's Role
Study Director
Facility Information:
City
Chandler
State/Province
Arizona
ZIP/Postal Code
85224
Country
United States
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85251
Country
United States
City
San Diego
State/Province
California
ZIP/Postal Code
92123
Country
United States
City
Santa Rosa
State/Province
California
ZIP/Postal Code
95405
Country
United States
City
Denver
State/Province
Colorado
ZIP/Postal Code
80239
Country
United States
City
Edgewater
State/Province
Florida
ZIP/Postal Code
32123
Country
United States
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
City
Summerfield
State/Province
Florida
ZIP/Postal Code
34491
Country
United States
Facility Name
Ocean Spray Cranberries Research Sites
City
Addison
State/Province
Illinois
ZIP/Postal Code
60101
Country
United States
City
Evanston
State/Province
Illinois
ZIP/Postal Code
60201
Country
United States
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55435
Country
United States
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45249
Country
United States
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43212
Country
United States
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
City
Pleasant Grove
State/Province
Utah
ZIP/Postal Code
84062
Country
United States
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84124
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
33596852
Citation
Straub TJ, Chou WC, Manson AL, Schreiber HL 4th, Walker BJ, Desjardins CA, Chapman SB, Kaspar KL, Kahsai OJ, Traylor E, Dodson KW, Hullar MAJ, Hultgren SJ, Khoo C, Earl AM. Limited effects of long-term daily cranberry consumption on the gut microbiome in a placebo-controlled study of women with recurrent urinary tract infections. BMC Microbiol. 2021 Feb 18;21(1):53. doi: 10.1186/s12866-021-02106-4.
Results Reference
derived
PubMed Identifier
27251185
Citation
Maki KC, Kaspar KL, Khoo C, Derrig LH, Schild AL, Gupta K. Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection. Am J Clin Nutr. 2016 Jun;103(6):1434-42. doi: 10.3945/ajcn.116.130542. Erratum In: Am J Clin Nutr. 2017 Aug;106(2):708.
Results Reference
derived
Learn more about this trial
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
We'll reach out to this number within 24 hrs